Yumeng Mao

发表

Tumour‐induced immune suppression: role of inflammatory mediators released by myelomonocytic cells

R. Kiessling, I. Poschke, Y. Mao, 2014, Journal of internal medicine.

Dendritic cell regulation of NK‐cell responses involves lymphotoxin‐α, IL‐12, and TGF‐β

R. Kiessling, A. Österborg, A. Lundqvist, 2015, European journal of immunology.

Cisplatin inhibits frequency and suppressive activity of monocytic myeloid-derived suppressor cells in cancer patients

R. Kiessling, C. V. van Herpen, I. D. de Vries, 2021, Oncoimmunology.

Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous Neuroblastoma

R. Kiessling, K. Blanc, P. Kogner, 2016, Clinical Cancer Research.

Inhibitory effect of selective cyclooxygenase-2 inhibitor NS-398 on proliferation and invasion of human colorectal cancer cells: Inhibitory effect of selective cyclooxygenase-2 inhibitor NS-398 on proliferation and invasion of human colorectal cancer cells

Y. Qiu, Y. Mao, Liang Si, 2009 .

Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines

R. Kiessling, F. Salazar-Onfray, G. Masucci, 2012, Cancer Immunology, Immunotherapy.

Phosphodiesterase 4A confers resistance to PGE2‐mediated suppression in CD25+/CD54+ NK cells

Shi-Yong Neo, K. Larsson, Yihai Cao, 2021, EMBO reports.

Melanoma-educated CD14+ cells acquire a myeloid-derived suppressor cell phenotype through COX-2-dependent mechanisms.

R. Kiessling, J. Hansson, I. Schultz, 2013, Cancer research.

Local release of highly loaded antibodies from functionalized nanoporous support for cancer immunotherapy.

Jun Liu, Baowei Chen, C. Lei, 2010, Journal of the American Chemical Society.

Inhibition of Tumor-Derived Prostaglandin-E2 Blocks the Induction of Myeloid-Derived Suppressor Cells and Recovers Natural Killer Cell Activity

B. Seliger, R. Kiessling, A. Lundqvist, 2014, Clinical Cancer Research.

Optimization of an Imidazo[1,2-a]pyridine Series to Afford Highly Selective Type I1/2 Dual Mer/Axl Kinase Inhibitors with In Vivo Efficacy.

E. Hennessy, Nichola L. Davies, A. Doherty, 2021, Journal of Medicinal Chemistry.

Biology of Human Tumors Inhibition of Tumor-Derived Prostaglandin-E 2 Blocks the Induction ofMyeloid-DerivedSuppressorCells andRecovers Natural Killer Cell Activity

B. Seliger, R. Kiessling, A. Lundqvist, 2014 .

Myeloid Suppressors Decrease Melanoma Survival by Abating Tumor-Fighting T Cells

R. Kiessling, Y. Mao, Yago Pico de Coaña, 2014, Clinical Cancer Research.

LRTCLS: low-rank tensor completion with Laplacian smoothing regularization for unveiling the post-transcriptional machinery of N6-methylation (m6A)-mediated diseases

Hui Liu, Lin Zhang, Jiani Ma, 2022, Briefings Bioinform..

HER2/HER3 Signaling Regulates NK Cell-Mediated Cytotoxicity via MHC Class I Chain-Related Molecule A and B Expression in Human Breast Cancer Cell Lines

B. Seliger, D. Mougiakakos, R. Kiessling, 2012, The Journal of Immunology.

The Next Generation of Pattern Recognition Receptor Agonists: Improving Response Rates in Cancer Immunotherapy.

Deanna A. Mele, Daniel H. O’ Donovan, Y. Mao, 2019, Current medicinal chemistry.

in Human Breast Cancer Cell Lines Chain-Related Molecule A and B Expression Cell-Mediated Cytotoxicity via MHC Class I HER2/HER3 Signaling Regulates NK

B. Seliger, D. Mougiakakos, R. Kiessling, 2012 .

Regulation of myeloid cells by activated T cells determines the efficacy of PD-1 blockade

R. Kiessling, Helene Andersson Svahn, Philippa Reuterswärd, 2016, Oncoimmunology.

Block CSF-1 R to improve checkpoint blockade in neuroblastoma 1 Targeting suppressive myeloid cells potentiates checkpoint inhibitors to control 1 spontaneous neuroblastoma 2

Rolf, Werner Kießling, K. Blanc, 2016 .

IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells.

R. Kiessling, O. Larsson, Shuo Liang, 2016, Blood.

Tumor-dependent increase of serum amino acid levels in breast cancer patients has diagnostic potential and correlates with molecular tumor subtypes

R. Kiessling, J. de Boniface, I. Poschke, 2013, Journal of Translational Medicine.

Discovery of PROTAC molecules that selectively degrade the IRAK3 pseudokinase.

Fiona Pachl, O. Tavana, S. Degorce, 2020, Journal of medicinal chemistry.

Ipilimumab treatment results in an early decrease in the frequency of circulating granulocytic myeloid derived suppressor cells as well as their arginase1 production

R. Kiessling, J. Hansson, G. Masucci, 2013, Journal of Translational Medicine.

IL-15 activates mTOR and primes stress-activated gene expression leading to prolonged antitumor capacity of NK cells.

R. Kiessling, O. Larsson, Shuo Liang, 2016, Blood.

Human ovarian cancer intrinsic mechanisms regulate lymphocyte activation in response to immune checkpoint blockade

S. Ghaem-Maghami, Y. Mao, Marina Natoli, 2020, Cancer Immunology, Immunotherapy.

Melanoma-educated CD14+ cells acquire a myeloid-derived suppressor cell phenotype through COX-2-dependent mechanisms.

R. Kiessling, J. Hansson, I. Schultz, 2013, Cancer research.

Cyclooxygenase-2

R. Kiessling, I. Poschke, Y. Mao, 2013 .

Tumor‐dependent down‐regulation of the ζ‐chain in T‐cells is detectable in early breast cancer and correlates with immune cell function

R. Kiessling, Y. Mao, J. Boniface, 2012, International journal of cancer.

Expression patterns of the immunomodulatory enzyme arginase 1 in blood, lymph nodes and tumor tissue of early-stage breast cancer patients

R. Kiessling, J. de Boniface, I. Poschke, 2012, Oncoimmunology.